scispace - formally typeset
Open AccessJournal ArticleDOI

Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics

Reads0
Chats0
TLDR
The COVAX Facility of the ACT Accelerator has agreements to access 2 billion doses of WHO prequalified vaccines during 2021, but this represents only 20% of the vaccine needs of participating countries Most low-income and middle-income countries face difficulties in accessing and delivering vaccines and therapeutics for COVID-19 to their populations.
About
This article is published in The Lancet.The article was published on 2021-02-13 and is currently open access. It has received 98 citations till now.

read more

Citations
More filters
Journal ArticleDOI

COVID-19 Mass Vaccination Campaign: An International Comparison of Qatar With GCC Nations and Other Global Groups

TL;DR: In this article , the authors focused on the case of Qatar in comparison with regional neighbors in the Gulf Cooperation Community (GCC) and with global benchmarks (G7 and OECD nations) in terms of the deployment of its mass vaccination program.
Posted ContentDOI

Which countries need COVID-19 vaccines the most? Development of a prioritisation tool

Hugo Darroman
TL;DR: In this paper , the authors identify the most important factors for assessing countries' needs for vaccines, and to weight each, generating a scoring tool for prioritising countries, which can build on existing methods to further the role of equity in global COVID-19 vaccine allocation.
Journal ArticleDOI

Country immunization policies for refugees across 20 low-middle income and 20 high-income countries

TL;DR: In this article , the authors collected and analyzed existing routine immunization policies for refugees across 20 low and middle-income countries (LMICs) and 20 high income countries (HICs), each with the highest number of refugees per 1000 residents.
Journal ArticleDOI

Reactogenicity of the BNT162b2 mRNA vaccine (Pfizer-BioNTech) against COVID-19 in workers of a tertiary hospital.

TL;DR: The distribution of reactogenicity in the present study is consistent with the data reported in previous studies on the BNT162b2 vaccine, especially in terms of its association with the participants' characteristics.
Posted ContentDOI

Special Olympics global report on COVID-19 vaccination and reasons not to vaccinate among adults with intellectual disabilities

TL;DR: In this paper , the authors identify global rates of COVID-19 vaccination and reasons not to vaccinate among adults with intellectual disabilities (ID) associated with country economic income levels.
References
More filters
Journal ArticleDOI

Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.

TL;DR: This study provides an overview of how high income countries have secured future supplies of covid-19 vaccines but that access for the rest of the world is uncertain.
Journal ArticleDOI

Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations.

TL;DR: This review will discuss the available immunologic and clinical evidence to support the benefit of the influenza, pneumococcal, and tuberculosis vaccines in the context of COVID-19 as well as to provide an overview on the CO VID-19-specific vaccines that are in the development pipeline.
Journal ArticleDOI

Strengthening medical product regulation in low- and middle-income countries.

TL;DR: Charles Preston and colleagues use case studies to describe how regulatory systems for medical products and medicines must be strengthened in low and middle income countries to assure adequate quality, safety and efficacy.
Related Papers (5)